Methods of treating ophthalmic conditions

Details for Australian Patent Application No. 2005269293 (hide)

Owner Allergan, Inc.

Inventors Wolde Mussie Elizabeth; Wheeler, Larry A.; Hare, William A.

Agent Davies Collison Cave

Pub. Number AU-A-2005269293

PCT Pub. Number WO2006/015075

Priority 60/591,423 26.07.04 US

Filing date 26 July 2005

Wipo publication date 9 February 2006

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015075 Priority application(s): WO2006/015075

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269310-Apparatus and method for processing video data

2005269289-Chlorine dioxide solution generator